The Role of Intraoperative Navigation-assisted Channel Screw Technique in the Treatment of Pelvic Fractures
INCST
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
This was a multicenter, prospective, randomized, controlled study. Patients with pelvic fractures (Tile B and c) were recruited from the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Red Society Hospital and Xi'an 521 hospital, the patients were randomly divided into two groups according to the Order of admission: Experimental Group (intraoperative navigation combined with channel screw technique) and Control Group (open reduction and plate internal fixation) , the difference of operative effect between the two groups was compared by fracture reduction, channel screw position, operative time, fluoroscopy frequency, hospitalization time, hospitalization cost, recovery time and Mayo Score. Use Access 2003 to build a database and store data; use SPSS 21.0. 0 Software for statistical analysis. The entire process required the development of a standardized staff manual, and all were subject to rigorous training and examination in order to participate in the pilot, and the investigation process was supervised by the project leader.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 4, 2022
CompletedFirst Posted
Study publicly available on registry
July 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedAugust 1, 2022
June 1, 2022
11 months
July 4, 2022
July 29, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Pelvic change
fracture displacement \< 4 mm was excellent, 4-10 mm was good, 10-20 mm was fair, and \> 20 mm was poor.
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 12 month
Secondary Outcomes (6)
screw position
follow-up of 3 months, 6 months and 12 months
pubic ramus screws
follow-up of 3 months, 6 months and 12 months
VAS scores VAS scores
follow-up of 3 months, 6 months and 12 months
The length of hospital stay
follow-up of 3 months, 6 months and 12 months
Total cost of hospitalization
follow-up of 3 months, 6 months and 12 months
- +1 more secondary outcomes
Study Arms (2)
Experimental group
EXPERIMENTALIt uses minimally invasive small incisions, physiological access to the pelvis, and hollow screws for Pelvic and Acetabular fractures
Control Group
OTHERThis approach typically requires extensive surgical exposure and large-scale soft-tissue dissection, which quickly leads to some serious complications, including increased rates of infection, poor wound healing, increased damage to large vessels or nerves, and heterotopic ossification
Interventions
It uses minimally invasive small incisions, physiological access to the pelvis, and hollow screws for Pelvic and Acetabular fractures
Open reduction and plate internal fixation is the most commonly used method to treat pelvic fracture, which can achieve anatomical reduction and rigid fixation. However, this method requires extensive dissection of the surrounding soft-tissue fracture and is invasive
Eligibility Criteria
You may qualify if:
- inpatients diagnosed with unstable pelvic acetabular fractures (tile B, C);
- sacroiliac joint dislocations and longitudinal sacral fractures that do not require sacral nerve or sacral canal decompression;
You may not qualify if:
- )stable posterior pelvic ring injury (Tile A type); 2)preoperative closed reduction to achieve functional reduction; 3)patients with severe osteoporosis; 4)heart, liver, kidney, and other essential organ lesions cannot tolerate surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2022
First Posted
July 8, 2022
Study Start
July 1, 2022
Primary Completion
June 1, 2023
Study Completion
January 1, 2025
Last Updated
August 1, 2022
Record last verified: 2022-06